A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine
Conditions: Herpes Zoster; Vaccine-Preventable Diseases Intervention: Biological: Recombinant Herpes Zoster Vaccine (LZ901) Sponsor: Beijing Luzhu Biotechnology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Herpes | Research | Shingles (Herpes Zoster) Vaccine | Study | Vaccines | Varicella-Zoster Virus Vaccine